M. Rudling et al., “Effects of Growth Hormone on Hepatic Cholesterol Metabolism. Lessons From Studies in Rats and Humans”, Growth Hormone & IGF Research, vol. 9, No. 1-7, pp. 1-7 (1999). |
Bo Angelin, “Therapy for Lowering Lipoprotein (a) Levels”, Current Opinion in Lipidology, vol. 8, pp. 337-341 (1977). |
Serena Tonstad et al, “The Effect of Growth Hormone on Low-Density Lipoprotein Cholesterol and Lipoprotein (a) Levels in Familial Hypercholesterolemia”, vol. 45, No. 11, pp. 1415-1421 (1996). |
M. Rudling et al, “Effects of Growth Hormone on Hepatic Cholesterol Metabolism”, Growth Hormone & IGF Research, 1999, pp. 1-7, vol. 9, No. 1-7. |
Bo Angelin, “Therapy for Lowering Lipoprotein (a) Levels”, Current Opinion in Lipidology, 1997, vol. 8, pp. 337-341. |
Serena Tonstad et al, “The Effect of Growth Hormone on Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Levels in Familial Hypercholesterolemia”, Metabolism, 1996, vol. 45, No. 11, pp. 1415-1421. |
Joseph L. Goldstein et al, “Familial Hypercholesterolemia”, Lipoprotein and Lipid Metabolism Disorders, 1995, Chapter 62, pp. 1981-2030, ed. by C.R. Scriver et al. New York: McGraw-Hill, 1995. |
Shun Ishibashi et al, “Hypercholsterolemia in Low Density Lipoprotein Receptor Knockout Mice and its Reversal by Adenovirus-mediated Gene Delivery”, J. Clinical Invest., Aug. 1993, vol. 92, pp. 883-893. |
Guorong Xu et al, “Unexpected Inhibition of Cholesterol 7α-Hydroxylase by Cholesterol in New Zealand White and Watanabe Heritable Hyperlipidemic Rabbits”, The Journal of Clinical Investigation, Inc., Apr. 1995, vol. 95, pp. 1497-1504. |
David K. Spady et al, “Adenovirus-mediated Transfer of a Gene Encoding Cholesterol 7α-Hydroxylase into Hamsters Increases Hepatic Enzyme Activity and Reduces Plasma Total and Low Density Lipoprotein Cholesterol”, J. Clin. Invest., Aug. 1995, vol. 96, pp. 700-709. |
A David Marais et al, “Decreased Production of Low Density Lipoprotein by Atorvastatin After Apheresis in Homozygous Familial Hypercholesterolemia”, Journal of Lipid Research, 1997, vol. 38, pp. 2071-2078. |
Mats Rudling et al, “Importance of Growth Hormone for the Induction of Hepatic Low Density Lipoprotein Receptors”, Proc. Natl. Acad. Sci. USA, Aug. 1992, vol. 89, pp. 6983-6987. |
Mats Rudling et al, “Growth Hormone and Bile Acid Synthesis” J. Clin. Invest., May 1997, vol. 99, No. 9, pp. 2239-2245. |
Paolo Parini et al, “Cholesterol and Lipoprotein Metabolism in Aging” Arterioscler Thromb Vasc Biol, Apr. 1999, vol. 19, pp. 832-839. |
Bo Angelin, “Therapy for Lowering Lipoprotein (a) Levels”, Current Opinion in Lipidology, 1997, vol. 8, pp. 337-341. |
Mats Rudling, “Hepatic mRNA levels for the LDL Receptor and HMG-CoA Reductase Show Coordinate Regulation in vivo”, Journal of Lipid Research, 1992, vol. 33, pp. 493-502. |
Bo Angelin et al, “3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Human Liver Microsomes: Active and Inactive Forms and Cross-Reactivity with Antibody Against Rat Liver Enzyme”, The Journal of Lipid Research, 1984, vol. 25, No. 11, pp. 1159-1166. |
Serena Tonstad et al, “The Effect of Growth Hormone on Low-Density Lipoprotein Cholesterol and Lipoprotein (a) Levels in Familial Hypercholesterolemia” Metabolism, 1996, vol. 45, No. 11, pp. 1415-1421. |
Kurt Einarsson et al, “Bile Acid Synthesis in Man: Assay of Hepatic Microsomal Cholesterol 7α-Hydroxylase Activity by Isotope Dilution-Mass Spectrometry”, Journal of Lipid Research, 1986, vol. 27, pp. 82-88. |
Kurt Einarsson et al, “Studies on Acyl-Coenzyme A: Cholesterol Acyltransferase Activity in Human Liver Microsomes”, Journal of Lipid Research, 1989, vol. 30, pp. 739-746. |
Sabine Wolle et al, “Hepatic Overexpression of Bovine Scavenger Receptor Type I in Transgenic Mice Prevents Diet-Induced Hyperbetalipoproteinemia”, J. Clin. Invest., Jul. 1995, vol. 96, pp. 260-272. |
William T. Beher et al, “Rapid Analysis of Human Fecal Bile Acids”, Steroids, Sep., 1981, vol. 38, No. 3, pp. 281-294. |